Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Mounjaro (tirzepatide): A GLP-1/GIP dual agonist medication indicated for type 2 diabetes, while its counterpart Zepbound focuses on weight loss
It binds to GHRH receptors in the pituitary and stimulates growth hormone secretion
GLP-1 use disclosure: A personal decision, not an obligation For most GLP-1 users, disclosing medication use to a romantic partner is a deeply personal call, and many are thoughtful about the timing
We measure how youre aging then design smarter, data-backed plans that grow with you
It means a 0.25mg weekly injection delivers more systemic semaglutide than a 1mg daily sublingual dose in many cases
US$ 22.26
US$ 28.55
US$ 21.62
US$ 26.56
US$ 25.52
US$ 26.79
